MarketBeat.com

Apple has lagged the broader market since the middle of last month. Historically, its shares have always bounced back once the technical indicators pointed to them being oversold. Last Friday, we saw...

Bluebird Bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. Bluebird bio's...

The U.S. IPO market kicks off on January 11 with Smith Douglas Homes, which expects a valuation of $1.08 billion. Companies that may go public this year include Reddit, Databricks, Stripe, Turo, Shein...

Chipotle Mexican Grill hit a top at the end of 2023, but new highs are in the forecast. The year's first five analysts' revisions have this stock trading at an all-time high. The bar for Q4 results is...

The U.S. Securities and Exchange Commission (SEC) is expected to decide on approving, denying, or pausing spot bitcoin ETFs by Jan. 10, 2024. Coinbase is the largest U.S. cryptocurrency exchange and...

Intel's 2023 rally still has legs, and 2024 looks just as bright. Several key tailwinds are in place, which should support a push for all-time highs. Even with recent gains, Intel's valuation remains...

By the end of 2023, the Magnificent 7 tech stocks accounted for about 33% of S&P 500 market cap. Analysts see reasons that many of these stocks can build on that outperformance in 2024. The...

ConAgra is a major manufacturer of packaged and frozen foods selling under iconic brands like Birds Eye, Slim Jim, Vlasic, Reddi-wip, and Orville Redenbacher. It produced its sixth consecutive...

Microsoft's cybersecurity business grew to about $20 billion annually as of January 2023. Traditional cybersecurity players like CrowdStrike and Palo Alto Networks now face competition from...

McDonald's is set to continue outperforming its fast-food peers. Meta shares should see fresh all-time highs in the coming weeks. Tesla stock is on the verge of waking up, and the outlook is...

The stock had a bumpy 2023 but is ending the year well ahead of its peers. Several key tailwinds are in place, which should support further gains. Aside from perhaps Tesla, Rivian remains one of the...

Buying the Dow Dogs doesn't mean it's time to sell the leaders. Letting winners run is an important factor in maximizing total returns. This year's winners could easily gain another double-digit...

Salesforce has had a great year, with further gains set to come in 2024. It’s the same with JFrog, though it’s had a softer year and is still in recovery mode. Both offer solid upside...

Ansys stock surged 18% on Synopsys acquisition news. Fellow software maker Altair, also seen as a potential acquisition target, advanced 11.48%. Analysts predict a 2024 M&A surge, despite...

Walgreens-Boots Alliance will be the top dog in 2023 and will pay one of the highest yields of any Dow stock. 3M is turning a corner after dodging several legal bullets; the stock is a value and...

The FQ4 reporting season will start soon, and earnings growth is expected to accelerate. Guidance for 2024 will be critical and could lead the S&P 500 to new highs. The risk is that consensus...